Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

DFTX holding history

Definium Therapeutics, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DFTX overviewAll 13F holders of DFTXFull Q2 2026 holdings

Shares (Q2 2026)
3,644,813
Value
$171.5M
% of portfolio
<0.1%
Quarters held
20
Since Q2 2021
Holdings of DFTX by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,644,813$171.5M<0.1%+1,149,414+46.1%AddedHolders
Q1 20262,495,399$47.2M<0.1%+162,461+7.0%AddedHolders
Q4 20252,332,938$31.2M<0.1%+508,237+27.9%AddedHolders
Q3 20251,824,701$21.5M<0.1%+91,247+5.3%AddedHolders
Q2 20251,733,454$11.3M<0.1%+66,663+4.0%AddedHolders
Q1 20251,666,791$9.75M<0.1%−56,297−3.3%ReducedHolders
Q4 20241,723,088$12.0M<0.1%+45,386+2.7%AddedHolders
Q3 20241,677,702$9.55M<0.1%+162,933+10.8%AddedHolders
Q2 20241,514,769$10.9M<0.1%+1,125,365+289.0%AddedHolders
Q1 2024389,404$3.66M<0.1%+11,489+3.0%AddedHolders
Q4 2023377,915$1.38M<0.1%+6,602+1.8%AddedHolders
Q3 2023371,313$1.16M<0.1%+303+0.1%AddedHolders
Q2 2023371,010$1.32M<0.1%+30,955+9.1%AddedHolders
Q1 2023340,055$1.08M<0.1%+58,384+20.7%AddedHolders
Q4 2022281,671$619.0K<0.1%+281,671NewHolders
Q3 20220$00.0%−13,410−100.0%Sold outConverted for a 1-for-15 splitHolders
Q2 2022201,145$129.0K<0.1%−2,621,537−92.9%ReducedHolders
Q1 20222,822,682$3.13M<0.1%−86,053−3.0%ReducedHolders
Q4 20212,908,735$4.01M<0.1%−4,298−0.1%ReducedHolders
Q3 20212,913,033$6.79M<0.1%+200,941+7.4%AddedHolders
Q2 20212,712,092$9.36M<0.1%+2,712,092NewHolders